TH129939B -
Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL).
- Google Patents
Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL).
Info
Publication number
TH129939B
TH129939BTH1201005970ATH1201005970ATH129939BTH 129939 BTH129939 BTH 129939BTH 1201005970 ATH1201005970 ATH 1201005970ATH 1201005970 ATH1201005970 ATH 1201005970ATH 129939 BTH129939 BTH 129939B
TH1201005970A2011-04-18
Composition for the treatment of chronic hepatitis B, which contains clevudine (CLEVUDINE) and adefovir dipivoxil (ADEFOVIR DIPIVOXIL).
TH129939B
(en)
Compounds derived from substituted benzylindazoles, bub1 kinase inhibitors; manufacturing procedure; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of hyperproliferative diseases.